Skip to main content

Table 1 Clinical characteristics of light chain amyloidosis patients.

From: Prognostic implication of late gadolinium enhancement on cardiac MRI in light chain (AL) amyloidosis on long term follow up

 

LGE+ (N = 23)

LGE- (N = 6)

p-value

Age (years)

63 ± 12

58 ± 9

0.35

Heart rate (beats per minute)

82 ± 21

71 ± 28

0.26

Systolic blood pressure (mm Hg)

117 ± 18

141 ± 39

0.2

Chemotherapy/Stem cell transplant (N/%)

21 (91)

6 (100)

1.0

NYHA Heart Failure Class (N/%)

  

0.19

I

8 (35)

5 (83)

 

II

9 (39)

1 (17)

 

III

1 (4)

0

 

IV

5 (22)

0

 

Laboratory

   

Low voltage on ECG (N/%)

15 (65)

1 (17)

0.06

Alkaline phosphatase (U/L)

141 ± 151

75 ± 23

0.13

Troponin I (μg/L)

0.51 ± 0.6

0.23 ± 0.3

0.33

MRI

   

Left ventricular ejection fraction (%)

66 ± 17

69 ± 12

0.8

Anteroseptal thickness (mm)

1.5 ± 0.4

1.12 ± 0.4

0.05

Inferolateral thickness (mm)

1.3 ± 0.4

0.9 ± 0.2

0.0003

Left ventricular mass index (g/m2)

81 ± 30

61 ± 10

0.01